Medtronic to acquire wearable insulin patch maker eoflow

Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless medtronic ecosystem of support dublin and seongnam, south korea , may 25, 2023 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire eoflow co. ltd. (kosdaq: 294090), manufacturer of the eopatch® device — a tubeless, wearable and fully disposable insulin delivery device.
MDT Ratings Summary
MDT Quant Ranking